abobotulinumtoxinA

Known as: abobotulinum toxin A, abobotulinumtoxin A 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2009-2017
010203020092017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
BACKGROUND The ANCHOR-CD prospective observational registry study evaluated the effectiveness of abobotulinumtoxinA in adult… (More)
  • table 1
  • table 2
Is this relevant?
2016
2016
BACKGROUND Although botulinum toxin is a well-established treatment of focal spasticity in cerebral palsy, most trials have been… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2015
2015
BACKGROUND Facial erythema is a frequent and often distressing complaint of patients with rosacea. Treatment of facial erythema… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
Is this relevant?
2015
2015
BACKGROUND Resistance from antagonistic muscle groups might be a crucial factor reducing function in chronic hemiparesis. The… (More)
Is this relevant?
2013
2013
To determine if abobotulinumtoxin A (AboBTXA) is an effective treatment for interstitial cystitis/bladder pain syndrome (IC/BPS… (More)
  • figure 1
  • table 1
  • table 2
Is this relevant?
2013
2013
BACKGROUND Three botulinum neurotoxin type A preparations (incobotulinumtoxinA, onabotulinumtoxinA, and abobotulinumtoxinA) are… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?
2012
2012
BACKGROUND Botulinum toxin A is effective for treatment of idiopathic detrusor overactivity (IDO). The trigone is generally… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
2012
2012
BACKGROUND The Food and Drug Administration has approved the reconstitution of botulinum toxin A with preservative-free saline… (More)
  • figure 1
Is this relevant?
2011
2011
OBJECTIVE To measure and compare the duration of action of abobotulinumtoxinA and onabotulinumtoxinA. DESIGN Randomized, double… (More)
Is this relevant?
2011
2011
BACKGROUND Studies on the pharmacodynamics of abobotulinumtoxinA (ABO) and onabotulinumtoxinA (ONA) have produced inconsistent… (More)
Is this relevant?